In vivo imaging of peripheral benzodiazepine receptors in mouse lungs: A biomarker of inflammation

Molecular Imaging

Volumn 4, Issue 4, 2005, Pages 432-438

  Hardwick, Matthew J ^a   Chen, Ming Kai ^b   Baidoo, Kwamena ^b   Pomper, Martin G ^c   Guilarte, Tomás R ^b,d  

^a Loyola College   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

(R) PK11195; In vivo imaging; Inflammation; Lps (lipopolysaccharide); Lungs; Peripheral benzodiazepine receptor; Positron emission tomography (PET)

Indexed keywords

(R)-PK11195; IN VIVO IMAGING; INFLAMMATION; LUNGS;

BIOLOGICAL ORGANS; CELL CULTURE; DISEASES; LIVING SYSTEMS STUDIES; POSITRON EMISSION TOMOGRAPHY; TISSUE;

MEDICAL IMAGING;

4 AMINOBUTYRIC ACID RECEPTOR; BIOLOGICAL MARKER; BZRP PROTEIN, MOUSE; CARBON; LIPOPOLYSACCHARIDE; RADIOACTIVE IODINE;

ANIMAL; ARTICLE; CHEMISTRY; IMMUNOLOGY; INFLAMMATION; LUNG; METABOLISM; METHODOLOGY; MOUSE; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; RADIOGRAPHY; VALIDATION STUDY;

ANIMALS; BIOLOGICAL MARKERS; CARBON RADIOISOTOPES; INFLAMMATION; IODINE RADIOISOTOPES; LIPOPOLYSACCHARIDES; LUNG; MICE; POSITRON-EMISSION TOMOGRAPHY; RECEPTORS, GABA;

EID: 31344475382     PISSN: 15353508     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. 3H]PK11195 binding to activated microglia. J Neurocytol. 26:77-82.
2. Chen MK, Baidoo K, Verina T, Guilarte TR (2004). Peripheral benzodiazepine receptor imaging in CNS demyelination: Functional implications of anatomical and cellular localization. Brain. 127:1379-1392.
3. Kuhlmann AC, Guilarte TR (1997). The peripheral benzodiazepine receptor is a sensitive indicator of domoic acid neurotoxicity. Brain Res. 751:281-288.
4. Kuhlmann AC, Guilarte TR (1999). Regional and temporal expression of the peripheral benzodiazepine receptor in mptp neurotoxicity. Toxicol Sci. 48:107-116.
5. Kuhlmann AC, Guilarte TR (2000). Cellular and subcellular localization of peripheral benzodiazepine receptors after trimethyltin neurotoxicity. J Neurochem. 74:1694-1704.
6. Mankowski JL, Queen SE, Tarwater PJ, Adams RJ, Guilarte TR (2003). Elevated peripheral benzodiazepine receptor expression in simian immunodeficiency virus encephalitis. J Neurovirol. 9: 94-100.
7. Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain. 123:2321-2337.
8. Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001). In-vivo measurement of activated microglia in dementia. Lancet. 358:461-467.
9. 11C] (R)-PK11195-PET following herpes encephalitis reveals projected neuronal damage beyond the primary focal lesion. Brain. 124:2014-2027.
10. 11nC]PK11195. Neurology. 55:1052-1054.
11. 123I]iodo-PK11195: A possible single-photon emission tomography tracer for visualization of inflammation. Eur J Nucl Med 26:194-200.
12. 123I]-iodo-PK11195 for mapping peripheral-type benzodiazepine receptors (omega 3) in heart. Nucl Med Biol. 23:23-28.
13. Canat X, Carayon P, Bouaboula M, Cahard D, Shire D, Roque C, Le Fur G, Casellas P (1993). Distribution profile and properties of peripheral-type benzodiazepine receptors on human hemopoietic cells. Life Sci. 52:107-118.
14. Ruff MR, Pert CB, Weber RJ, Wahl LM, Wahl SM, Paul SM (1985). Benzodiazepine receptor-mediated chemotaxis of human monocytes. Science. 229:1281-1283.
15. Zavala F, Veber F, Descamps-Latscha B (1990). Altered expression of neutrophil peripheral benzodiazepine receptor in x-linked chronic granulomatous disease. Blood. 76:184-188.
16. Zavala F, Taupin V, Descamps-Latscha B (1990). In vivo treatment with benzodiazepines inhibits murine phagocyte oxidative metabolism and production of interleukin 1, tumor necrosis factor and interleukin-6. J Pharmacol Exp Ther. 255: 442-450.
17. Torres SR, Frode TS, Nardi GM, Vita N, Reeb R, Ferrara P, Ribeiro-do-Valle RM, Farges RC (2000). Anti-inflammatory effects of peripheral benzodiazepine receptor ligands in two mouse models of inflammation. Eur J Pharmacol. 408:199-211.
18. Mak JC, Barnes PJ (1990). Peripheral type benzodiazepine receptors in human and guinea pig lung: Characterization and autoradiographic mapping. J Pharmacol Exp Ther. 252:880-885.
19. Seidel J, Vaquero J, Green M (2001). Resolution uniformity and sensitivity of the NIH ATsmall animal pet scanner: Comparison to simulated ISO scanners without depth-of-interaction capability. IEEE Nucl Sci Symp Conf Rec 1555-1558.
20. Gildersleeve DL, Lin TY, Wieland DM, Ciliax BJ, Olson JM, Young AB (1989). Synthesis of a high specific activity 1251-labeled analog of PK 11195, potential agent for SPECT imaging of the peripheral benzodiazepine binding site. Int J Rad Appl Instrum B. 16:423-429.
21. Camsonne R, Crouzel C, Comar D, Maziere M, Prenant C, Sastre J, Moulin M, Syrota A (1984). Synthesis of N-(11C)methyl, N-(1methylpropyl), 1-(2-chlorophenyl)isoquinoleine carboxamide-3 (PK 11195): A new ligand for peripheral benzodiazepine receptors. J Labelled Compd Radiopharm. 21:985-991.
22. Harmsen AG (1988). Role of alveolar macrophages in lipopolysaccharide- induced neutrophil accumulation. Infect Immun. 56:1858-1863.
23. Lefort J, Singer M, Leduc D, Renesto P, Nahori MA, Huerre M, Creminon C, Chignard M, Vargaftig BB (1998). Systemic administration of endotoxin induces bronchopulmonary hyperreactivity dissociated from TNF-alpha formation and neutrophil sequestration into the murine lungs. J Immunol. 161: 474-480.
24. Jones HA, Valind SO, Clark IC, Bolden GE, Krausz T, Schofield JB, Boobis AR, Haslett C (2002). Kinetics of lung macrophages monitored in vivo following particulate challenge in rabbits. Toxicol Appl Pharmacol. 183:46-54.
25. Jones HA, Marino PS, Shakur BH, Morrell NW (2003). In vivo assessment of lung inflammatory cell activity in patients with COPD and asthma. Eur Respir J. 21:567-573.
26. Pomper MG (2002). Can small animal imaging accelerate drug development? J Cell Biochem Suppl. 39:211-220.